ArticleOncology letters2013

Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.

Umut Kefeli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.